Loading...

Kathryn Phillips, PhD

TitleProfessor
SchoolUCSF School of Pharmacy
DepartmentClinical Pharmacy
Address3333 Calif. St,Laurel Heights
San Francisco CA 94118
Phone415-502-8271
EmailKathryn.Phillips@ucsf.edu
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    UCSFPost-doctoral fellowship
    Kennedy School of Government Harvard UniversityMC-MPA
    University of Texas at AustinBA
    Collapse Awards and Honors
    Harvard/Dept of Navy (civilian)1985 - 1986Training Award for mid-career Master's Degree
    UC Berkeley1987 - 1988UC Berkeley Graduate Fellowship
    UC-Berkeley1989 - 1989Outstanding Graduate Student Instructor
    Am J Prev Med1999 - 1999Commendation for outstanding journal reviews
    Univ of CT2003 - 200350 Most Cited HIV Behavioral Researchers in Past Decade
    Research Triangle Institute2010 - 2010Most cited article award
    Bellagio Center Italy2016Rockefeller Foundation Residency

    Collapse Overview 
    Collapse overview
    Kathryn A. Phillips, PhD, a health services researcher and health economist and leader in the application of new technologies to improve healthcare, is the founding director of the Center for Translational and Policy Research on Personalized Medicine (TRANSPERS) in the School of Pharmacy at the University of California, San Francisco (UCSF). She is also a professor of health economics and health services research in the Department of Clinical Pharmacy at UCSF, with additional appointments in the UCSF Philip R. Lee Institute for Health Policy Studies and UCSF Helen Diller Family Comprehensive Cancer Center

    Kathryn focuses on the value of new technologies and how to most effectively and efficiently implement them into health care. Her core specialty is personalized (or precision) medicine — a new era of healthcare where medical interventions can be tailored to individual patients based on their unique genetic make-up. Her work spans multiple disciplines, including basic, clinical and social sciences, and brings together leading experts in academia, industry, healthcare, payers, and government. Kathryn led one of the earliest studies on the societal implications of pharmacogenomics, underscoring its potential to reduce the incidence of adverse drug reactions (JAMA, 2001). Her pioneering research on the application of health services research to personalized medicine has revealed insights on how to bridge the gap between emerging technologies and their use in the clinic. Kathryn has also conducted seminal work on HIV, as her analysis of HIV home testing informed the FDA’s decision to approve the first home collection HIV test (New England Journal of Medicine, 1995).

    Kathryn has published more than 100 peer-reviewed articles in major journals, including JAMA, the New England Journal of Medicine, and Health Affairs and has had continuous funding from the US. National Institutes of Health as a principal investigator for 25 years. She currently serves on the editorial boards of the journal Health Affairs (rated as the top policy journal) and several leading journals on personalized medicine. Kathryn has served on national and international scientific advisory committees and workshops including work for GenomeCanada, Institutes of Medicine, Food and Drug Administration, Centers for Disease Control and Prevention, and the President’s Council of Advisors on Science and Technology. She has also served as an advisor to various international and industry organizations, including more than 35 biotechnology companies and venture capital firms. Most recently, she has been asked by the Patient-Centered Outcomes Research Institute (PCORI) - the largest funder of comparative effectiveness research in the world - to develop potential topics for their research agenda on personalized/precision medicine.


    Collapse Research 
    Collapse Research Activities and Funding
    Risk-Benefit Trade-Offs for Whole Genome Sequencing
    NIH/NHGRI R01HG007063Feb 15, 2013 - Jan 31, 2017
    Role: Principal Investigator
    Personalized Medicine for Colorectal and Breast Cancer
    NIH/NCI P01CA130818Sep 16, 2008 - Aug 31, 2013
    Role: Principal Investigator
    Screening for Colorectal Cancer: An Integrated Approach
    NIH/NCI R01CA101849Apr 28, 2004 - Mar 31, 2009
    Role: Principal Investigator
    USE OF CANCER SCREENING IN A MANAGED CARE ENVIRONMENT
    NIH/NCI R01CA081130Feb 1, 2000 - Apr 30, 2004
    Role: Principal Investigator
    UTILIZATION AND COST EFFECTIVENESS OF NEW HIV TESTS
    NIH/NIAID R01AI043744Jul 1, 1999 - Aug 31, 2003
    Role: Principal Investigator
    EFFECTIVENESS AND COST-EFFECTIVENESS OF HIV TESTING
    NIH/NIAID R29AI034864Dec 1, 1993 - Nov 30, 1999
    Role: Principal Investigator
    GOVERNMENT INTERVENTION AND UTILIZATION OF HIV SCREENING
    AHRQ R03HS006629Sep 1, 1990 - Aug 31, 1991
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Global Health
    Collapse Featured Videos
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Selected Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Dervan AP, Deverka PA, Trosman JR, Weldon CB, Douglas MP, Phillips KA. Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening. Genet Med. 2016 Sep 22. PMID: 27657682.
      View in: PubMed
    2. Phillips KA, Schleifer D, Hagelskamp C. Most Americans Do Not Believe That There Is An Association Between Health Care Prices And Quality Of Care. Health Aff (Millwood). 2016 Apr 1; 35(4):647-53. PMID: 27044965.
      View in: PubMed
    3. Clain E, Trosman JR, Douglas MP, Weldon CB, Phillips KA. Availability and payer coverage of BRCA1/2 tests and gene panels. Nat Biotechnol. 2015 Sep; 33(9):900-2. PMID: 26348951; PMCID: PMC4625918.
    4. Phillips KA, Pletcher MJ, Ladabaum U. Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing. Technol Health Care. 2015 Jun 10; 23(3):373-9. PMID: 25669213; PMCID: PMC4527943.
    5. Douglas MP, Ladabaum U, Pletcher MJ, Marshall DA, Phillips KA. Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review. Genet Med. 2016 Feb; 18(2):111-6. PMID: 25996638.
      View in: PubMed
    6. Trosman JR, Weldon CB, Kelley RK, Phillips KA. Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in. J Natl Compr Canc Netw. 2015 Mar; 13(3):311-8. PMID: 25736008; PMCID: PMC4372087.
    7. Foster DG, Biggs MA, Phillips KA, Grindlay K, Grossman D. Potential public sector cost-savings from over-the-counter access to oral contraceptives. Contraception. 2015 May; 91(5):373-9. PMID: 25732570.
      View in: PubMed
    8. Knight SJ, Mohamed AF, Marshall DA, Ladabaum U, Phillips KA, Walsh JM. Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample. Med Decis Making. 2015 Jan 14. PMID: 25589525.
      View in: PubMed
    9. Phillips KA, Labno A. Private Companies Providing Health Care Price Data: Who Are They and What Information do They Provide? J Manag Care Med. 2014 Oct 1; 17(4):75-80. PMID: 25678764.
      View in: PubMed
    10. Phillips KA, Trosman JR, Kelley RK, Pletcher MJ, Douglas MP, Weldon CB. Genomic sequencing: assessing the health care system, policy, and big-data implications. Health Aff (Millwood). 2014 Jul; 33(7):1246-53. PMID: 25006153; PMCID: PMC4113721.
    11. Balakrishnan N, Pritchard J, Ericson M, Grindem C, Phillips K, Jennings S, Mathews K, Tran H, Birkenheuer AJ, Breitschwerdt EB. Prostatitis, steatitis, and diarrhea in a dog following presumptive flea-borne transmission of Bartonella henselae. J Clin Microbiol. 2014 Sep; 52(9):3447-52. PMID: 24920774; PMCID: PMC4313127.
    12. Phillips KA, Ann Sakowski J, Trosman J, Douglas MP, Liang SY, Neumann P. The economic value of personalized medicine tests: what we know and what we need to know. Genet Med. 2014 Mar; 16(3):251-7. PMID: 24232413; PMCID: PMC3949119.
    13. Liang SY, Grossman D, Phillips KA. User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives. Contraception. 2012 Dec; 86(6):666-72. PMID: 22770791.
      View in: PubMed
    14. Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U. Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome. Am J Manag Care. 2012 May; 18(5):e179-85. PMID: 22694112.
      View in: PubMed
    15. Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U. Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. J Oncol Pract. 2012 May; 8(3 Suppl):e24s-30s. PMID: 22942831; PMCID: PMC3348599.
    16. Wang G, Beattie MS, Ponce NA, Phillips KA. Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling. Genet Med. 2011 Dec; 13(12):1045-50. PMID: 21844812; PMCID: PMC4537294.
    17. Elkin EB, Marshall DA, Kulin NA, Ferrusi IL, Hassett MJ, Ladabaum U, Phillips KA. Economic evaluation of targeted cancer interventions: critical review and recommendations. Genet Med. 2011 Oct; 13(10):853-60. PMID: 21637102; PMCID: PMC3774033.
    18. Kiely BE, Friedlander ML, Milne RL, Stanhope L, Russell P, Jenkins MA, Weideman P, McLachlan SA, Grant P, Hopper JL, Phillips KA. Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer. Fam Cancer. 2011 Sep; 10(3):505-14. PMID: 21424757; PMCID: PMC3175342.
    19. Harvey SL, Milne RL, McLachlan SA, Friedlander ML, Birch KE, Weideman P, Goldgar D, Hopper JL, Phillips KA. Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families. Breast Cancer Res Treat. 2011 Dec; 130(3):1057-61. PMID: 21850394.
      View in: PubMed
    20. Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2011 Jul 19; 155(2):69-79. PMID: 21768580; PMCID: PMC3793257.
    21. Haas JS, Liang SY, Hassett MJ, Shiboski S, Elkin EB, Phillips KA. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat. 2011 Nov; 130(2):619-26. PMID: 21681446; PMCID: PMC3590013.
    22. Liang SY, Phillips KA, Wang G, Keohane C, Armstrong J, Morris WM, Haas JS. Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care. 2011 Jun; 49(6):e1-8. PMID: 21422962; PMCID: PMC3383782.
    23. Trosman JR, Van Bebber SL, Phillips KA. Health technology assessment and private payers' coverage of personalized medicine. J Oncol Pract. 2011 May; 7(3 Suppl):18s-24s. PMID: 21886515; PMCID: PMC3092460.
    24. Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. J Oncol Pract. 2011 May; 7(3 Suppl):e1s-7s. PMID: 21886507; PMCID: PMC3092459.
    25. Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care. 2011 May; 17(5 Spec No):e174-81. PMID: 21711068.
      View in: PubMed
    26. Trosman JR, Van Bebber SL, Phillips KA. Health technology assessment and private payers's coverage of personalized medicine. Am J Manag Care. 2011 May; 17 Suppl 5 Developing:SP53-60. PMID: 21711078.
      View in: PubMed
    27. Johnson FR, Mohamed AF, Ozdemir S, Marshall DA, Phillips KA. How does cost matter in health-care discrete-choice experiments? Health Econ. 2011 Mar; 20(3):323-30. PMID: 20217834; PMCID: PMC3918954.
    28. Kelley RK, Van Bebber SL, Phillips KA, Venook AP. Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw. 2011 Jan; 9(1):13-25. PMID: 21233242; PMCID: PMC3695822.
    29. Liang SY, Grossman D, Phillips KA. Women's out-of-pocket expenditures and dispensing patterns for oral contraceptive pills between 1996 and 2006. Contraception. 2011 Jun; 83(6):528-36. PMID: 21570550.
      View in: PubMed
    30. Trosman JR, Van Bebber SL, Phillips KA. Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay. J Oncol Pract. 2010 Sep; 6(5):238-42. PMID: 21197187; PMCID: PMC2936466.
    31. Van Bebber SL, Trosman JR, Liang SY, Wang G, Marshall DA, Knight S, Phillips KA. Capacity building for assessing new technologies: approaches to examining personalized medicine in practice. Per Med. 2010 Jul; 7(4):427-439. PMID: 21857867.
      View in: PubMed
    32. Phillips KA, Grossman D, Weitz TA, Trussell J. Bringing evidence to the debate on abortion coverage in health reform legislation: findings from a national survey in the United States. Contraception. 2010 Aug; 82(2):129-30. PMID: 20654752; PMCID: PMC4449358.
    33. Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JM, Marshall JK, Van Bebber S, Phillips KA. How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ. 2009 Dec; 18(12):1420-39. PMID: 19191268; PMCID: PMC3964796.
    34. Liang SY, Haas JS, Phillips KA. Medicare formulary coverage for top-selling biologics. Nat Biotechnol. 2009 Dec; 27(12):1082-4. PMID: 20010576; PMCID: PMC2845541.
    35. Phillips KA, Marshall DA, Haas JS, Elkin EB, Liang SY, Hassett MJ, Ferrusi I, Brock JE, Van Bebber SL. Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer. 2009 Nov 15; 115(22):5166-74. PMID: 19753618; PMCID: PMC2783254.
    36. Johnson FR, Ozdemir S, Phillips KA. Effects of simplifying choice tasks on estimates of taste heterogeneity in stated-choice surveys. Soc Sci Med. 2010 Jan; 70(2):183-90. PMID: 19880234; PMCID: PMC3152257.
    37. Ikediobi ON, Shin J, Nussbaum RL, Phillips KA, Walsh JM, Ladabaum U, Marshall D. Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther. 2009 Jul; 86(1):28-31. PMID: 19536122; PMCID: PMC2910521.
    38. Ferrusi IL, Marshall DA, Kulin NA, Leighl NB, Phillips KA. Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses. Per Med. 2009 Mar; 6(2):193-215. PMID: 20668661.
      View in: PubMed
    39. Wideroff L, Phillips KA, Randhawa G, Ambs A, Armstrong K, Bennett CL, Brown ML, Donaldson MS, Follen M, Goldie SJ, Hiatt RA, Khoury MJ, Lewis G, McLeod HL, Piper M, Powell I, Schrag D, Schulman KA, Scott J. A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics. 2009; 12(4):233-44. PMID: 19367091; PMCID: PMC2844634.
    40. Phillips KA. Closing the evidence gap in the use of emerging testing technologies in clinical practice. JAMA. 2008 Dec 3; 300(21):2542-4. PMID: 19050197; PMCID: PMC2910511.
    41. Phillips KA, Liang SY, Van Bebber S. Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value. Curr Opin Mol Ther. 2008 Jun; 10(3):260-6. PMID: 18535933; PMCID: PMC2910510.
    42. Lee JA, Afable-Munsuz A, Van Bebber SL, Phillips KA. Insured women and payment for elective abortion. Womens Health Issues. 2008 Sep-Oct; 18(5):347-50. PMID: 18468919.
      View in: PubMed
    43. Haas JS, Fitzmaurice G, Brawarsky P, Liang SY, Hiatt RA, Klabunde CN, Brown ML, Phillips KA. Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis. 2007 Oct; 4(4):A90. PMID: 17875265; PMCID: PMC2099288.
    44. Issa AM, Phillips KA, Van Bebber S, Nidamarthy HG, Lasser KE, Haas JS, Alldredge BK, Wachter RM, Bates DW. Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf. 2007 Sep; 2(3):177-85. PMID: 18690965.
      View in: PubMed
    45. Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007 Sep-Oct; 10(5):415-30. PMID: 17888107.
      View in: PubMed
    46. Gellad WF, Huskamp HA, Phillips KA, Haas JS. Angiotensin receptor blockers on the formularies of Medicare drug plans. J Gen Intern Med. 2007 Aug; 22(8):1172-5. PMID: 17503103; PMCID: PMC2305745.
    47. Phillips KA, Liang SY, Ladabaum U, Haas J, Kerlikowske K, Lieberman D, Hiatt R, Nagamine M, Van Bebber SL. Trends in colonoscopy for colorectal cancer screening. Med Care. 2007 Feb; 45(2):160-7. PMID: 17224779.
      View in: PubMed
    48. Liang SY, Phillips KA, Haas JS. Measuring managed care and its environment using national surveys: a review and assessment. Med Care Res Rev. 2006 Dec; 63(6 Suppl):9S-36S. PMID: 17099128.
      View in: PubMed
    49. Afable-Munsuz A, Gould H, Stewart F, Phillips KA, Van Bebber SL, Moore C. Provider practice models for and costs of delivering medication abortion -- evidence from 11 US abortion care settings. Contraception. 2007 Jan; 75(1):45-51. PMID: 17161124.
      View in: PubMed
    50. Liang SY, Phillips KA, Nagamine M, Ladabaum U, Haas JS. Rates and predictors of colorectal cancer screening. Prev Chronic Dis. 2006 Oct; 3(4):A117. PMID: 16978492; PMCID: PMC1779281.
    51. Keenan PS, Neumann PJ, Phillips KA. Biotechnology and Medicare's new technology policy: lessons from three case studies. Health Aff (Millwood). 2006 Sep-Oct; 25(5):1260-9. PMID: 16966721.
      View in: PubMed
    52. Phillips KA. The intersection of biotechnology and pharmacogenomics: health policy implications. Health Aff (Millwood). 2006 Sep-Oct; 25(5):1271-80. PMID: 16966723.
      View in: PubMed
    53. Kim S, Phillips WR, Pinsky L, Brock D, Phillips K, Keary J. A conceptual framework for developing teaching cases: a review and synthesis of the literature across disciplines. Med Educ. 2006 Sep; 40(9):867-76. PMID: 16925637.
      View in: PubMed
    54. Tiller K, Meiser B, Gaff C, Kirk J, Dudding T, Phillips KA, Friedlander M, Tucker K. A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer. Med Decis Making. 2006 Jul-Aug; 26(4):360-72. PMID: 16855125.
      View in: PubMed
    55. Phillips KA, Van Bebber S, Marshall D, Walsh J, Thabane L. A review of studies examining stated preferences for cancer screening. Prev Chronic Dis. 2006 Jul; 3(3):A75. PMID: 16776876; PMCID: PMC1636712.
    56. Phillips KA, Van Bebber SL. Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration. Med Care Res Rev. 2006 Jun; 63(3):301-26. PMID: 16651395.
      View in: PubMed
    57. Phillips KA, Van Bebber S, Issa AM. Diagnostics and biomarker development: priming the pipeline. Nat Rev Drug Discov. 2006 Jun; 5(6):463-9. PMID: 16718275.
      View in: PubMed
    58. Ladabaum U, Phillips KA. Colorectal cancer screening differential costs for younger versus older Americans. Am J Prev Med. 2006 May; 30(5):378-84. PMID: 16627125.
      View in: PubMed
    59. Van Bebber SL, Phillips KA, Weitz TA, Gould H, Stewart F. Patient costs for medication abortion: results from a study of five clinical practices. Womens Health Issues. 2006 Jan-Feb; 16(1):4-13. PMID: 16487919.
      View in: PubMed
    60. Gellad WF, Huskamp HA, Phillips KA, Haas JS. How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood). 2006 Jan-Feb; 25(1):248-55. PMID: 16403761; PMCID: PMC1403812.
    61. Phillips KA, Ackerman MJ, Sakowski J, Berul CI. Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index cases. Heart Rhythm. 2005 Dec; 2(12):1294-300. PMID: 16360080.
      View in: PubMed
    62. Phillips KA, Liang SY, Haas JS, Stebbins M, Alldredge BK. Prescription drug dispensing limits and patterns. Manag Care Interface. 2005 Jul; 18(7):41-6. PMID: 16060485.
      View in: PubMed
    63. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med. 2005 Jun 7; 142(11):891-7. PMID: 15941695.
      View in: PubMed
    64. Phillips KA, Van Bebber SL. Measuring the value of pharmacogenomics. Nat Rev Drug Discov. 2005 Jun; 4(6):500-9. PMID: 15915153.
      View in: PubMed
    65. Gemperli MP, Stewart FH, Phillips KA, Sakowski J, Van Bebber S, Bergthold L. A qualitative study of insurers' coverage for mifepristone-induced abortion. Manag Care Interface. 2005 Mar; 18(3):26-30, 32. PMID: 15816295.
      View in: PubMed
    66. Phillips KA, Van Bebber SL. A systematic review of cost-effectiveness analyses of pharmacogenomic interventions. Pharmacogenomics. 2004 Dec; 5(8):1139-49. PMID: 15584880.
      View in: PubMed
    67. Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn D. The effect of area HMO market share on cancer screening. Health Serv Res. 2004 Dec; 39(6 Pt 1):1751-72. PMID: 15533185; PMCID: PMC1361096.
    68. Haggstrom DA, Phillips KA, Liang SY, Haas JS, Tye S, Kerlikowske K. Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States). Cancer Causes Control. 2004 Nov; 15(9):883-92. PMID: 15577290.
      View in: PubMed
    69. Phillips KA, Veenstra DL, Ramsey SD, Van Bebber SL, Sakowski J. Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs. Am J Manag Care. 2004 Jul; 10(7 Pt 1):425-32. PMID: 15298364.
      View in: PubMed
    70. Haas JS, Phillips KA, Sonneborn D, McCulloch CE, Baker LC, Kaplan CP, Pérez-Stable EJ, Liang SY. Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care. 2004 Jul; 42(7):707-14. PMID: 15213496.
      View in: PubMed
    71. Sakowski JA, Phillips KA, Liang SY, Haas JS. Willingness to recommend a health plan: who is dissatisfied and what don't they like? Am J Manag Care. 2004 Jun; 10(6):393-400. PMID: 15209483.
      View in: PubMed
    72. Phillips KA, Haas JS, Liang SY, Baker LC, Tye S, Kerlikowske K, Sakowski J, Spetz J. Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res. 2004 Feb; 39(1):153-78. PMID: 14965082; PMCID: PMC1360999.
    73. Liang SY, Phillips KA, Tye S, Haas JS, Sakowski J. Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services. Am J Manag Care. 2004 Feb; 10(2 Pt 1):99-107. PMID: 15011810.
      View in: PubMed
    74. Tye S, Phillips KA, Liang SY, Haas JS. Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res. 2004 Feb; 39(1):179-206. PMID: 14965083; PMCID: PMC1361000.
    75. Phillips KA, Stotland NE, Liang SY, Spetz J, Haas JS, Oren E. Out-of-pocket expenditures for oral contraceptives and number of packs per purchase. J Am Med Womens Assoc. 2004; 59(1):36-42. PMID: 14768985.
      View in: PubMed
    76. Haas JS, Lee LB, Kaplan CP, Sonneborn D, Phillips KA, Liang SY. The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents. Am J Public Health. 2003 Dec; 93(12):2105-10. PMID: 14652342; PMCID: PMC1448160.
    77. Maddala T, Phillips KA, Reed Johnson F. An experiment on simplifying conjoint analysis designs for measuring preferences. Health Econ. 2003 Dec; 12(12):1035-47. PMID: 14673812.
      View in: PubMed
    78. Phillips KA. Important step forward in HIV-testing technologies [correction of technolgies]. Am J Prev Med. 2003 Aug; 25(2):167. PMID: 12880887.
      View in: PubMed
    79. Phillips KA, Veenstra D, Van Bebber S, Sakowski J. An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics. Pharmacogenomics. 2003 May; 4(3):231-9. PMID: 12718713.
      View in: PubMed
    80. Haas JS, Phillips KA, Baker LC, Sonneborn D, McCulloch CE. Is the prevalence of gatekeeping in a community associated with individual trust in medical care? Med Care. 2003 May; 41(5):660-8. PMID: 12719690.
      View in: PubMed
    81. Phillips KA, Chen JL. Willingness to use instant home HIV tests: data from the California Behavioral Risk Factor Surveillance Survey. Am J Prev Med. 2003 May; 24(4):340-8. PMID: 12726872.
      View in: PubMed
    82. Phillips KA, Bayer R, Chen JL. New Centers for Disease Control and Prevention's guidelines on HIV counseling and testing for the general population and pregnant women. J Acquir Immune Defic Syndr. 2003 Feb 1; 32(2):182-91. PMID: 12571528.
      View in: PubMed
    83. Phillips KA, Spetz J, Haas JS. Viagra and contraceptives. Health Aff (Millwood). 2003 Jan-Feb; 22(1):277. PMID: 12528859.
      View in: PubMed
    84. Phillips KA, Johnson FR, Maddala T. Measuring what people value: a comparison of "attitude" and "preference" surveys. Health Serv Res. 2002 Dec; 37(6):1659-79. PMID: 12546291; PMCID: PMC1464045.
    85. Phillips KA, Maddala T, Johnson FR. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res. 2002 Dec; 37(6):1681-705. PMID: 12546292; PMCID: PMC1464051.
    86. Haas JS, Phillips KA, Sonneborn D, McCulloch CE, Liang SY. Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care. 2002 Sep; 40(9):743-51. PMID: 12218765.
      View in: PubMed
    87. Oren E, McCart G, Phillips KA. Evaluating the potential impact of pharmacogenomics on ADRs. J Manag Care Pharm. 2002 Jul-Aug; 8(4):285-90. PMID: 14613422.
      View in: PubMed
    88. Phillips KA, Chen JL. Impact of the U.S. panel on cost-effectiveness in health and medicine. Am J Prev Med. 2002 Feb; 22(2):98-105. PMID: 11818178.
      View in: PubMed
    89. Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA. 2001 Nov 14; 286(18):2270-9. PMID: 11710893.
      View in: PubMed
    90. Goldman L, Phillips KA, Coxson P, Goldman PA, Williams L, Hunink MG, Weinstein MC. The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. J Am Coll Cardiol. 2001 Oct; 38(4):1012-7. PMID: 11583874.
      View in: PubMed
    91. Skolnik HS, Phillips KA, Binson D, Dilley JW. Deciding where and how to be tested for HIV: what matters most? J Acquir Immune Defic Syndr. 2001 Jul 1; 27(3):292-300. PMID: 11464151.
      View in: PubMed
    92. Phillips KA, Shlipak MG, Coxson P, Heidenreich PA, Hunink MG, Goldman PA, Williams LW, Weinstein MC, Goldman L. Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA. 2000 Dec 6; 284(21):2748-54. PMID: 11105180.
      View in: PubMed
    93. Phillips KA, Veenstra DL, Sadee W. Implications of the genetics revolution for health services research: pharmacogenomics and improvements in drug therapy. Health Serv Res. 2000 Dec; 35(5 Pt 3):128-40. PMID: 16148957; PMCID: PMC1383600.
    94. Phillips KA, Fernyak S. The cost-effectiveness of expanded HIV counselling and testing in primary care settings: a first look. AIDS. 2000 Sep 29; 14(14):2159-69. PMID: 11061658.
      View in: PubMed
    95. Shea MT, Zlotnick C, Dolan R, Warshaw MG, Phillips KA, Brown P, Keller MB. Personality disorders, history of trauma, and posttraumatic stress disorder in subjects with anxiety disorders. Compr Psychiatry. 2000 Sep-Oct; 41(5):315-25. PMID: 11011826.
      View in: PubMed
    96. Phillips KA, Mayer ML, Aday LA. Barriers to care among racial/ethnic groups under managed care. Health Aff (Millwood). 2000 Jul-Aug; 19(4):65-75. PMID: 10916961.
      View in: PubMed
    97. Phillips KA, Morin S, Coates T, Fernyak S, Marsh A, Ramos-Irizarry L. Home sample collection for HIV testing. JAMA. 2000 Jan 12; 283(2):198-9. PMID: 10634330.
      View in: PubMed
    98. Phillips KA, Fernyak S, Potosky AL, Schauffler HH, Egorin M. Use of preventive services by managed care enrollees: an updated perspective. Health Aff (Millwood). 2000 Jan-Feb; 19(1):102-16. PMID: 10645076.
      View in: PubMed
    99. Veenstra DL, Higashi MK, Phillips KA. Assessing the cost-effectiveness of pharmacogenomics. AAPS PharmSci. 2000; 2(3):E29. PMID: 11741245; PMCID: PMC2761139.
    100. Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA. 1999 Dec 8; 282(22):2156-63. PMID: 10591338.
      View in: PubMed
    101. Phillips KA. Breast carcinoma in carriers of BRCA1 or BRCA2 mutations: implications of proposed distinct histologic phenotypes. Cancer. 1998 Dec 1; 83(11):2251-4. PMID: 9840523.
      View in: PubMed
    102. Phillips KA, Morrison KR, Andersen R, Aday LA. Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization. Health Serv Res. 1998 Aug; 33(3 Pt 1):571-96. PMID: 9685123; PMCID: PMC1070277.
    103. Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML. Factors associated with women's adherence to mammography screening guidelines. Health Serv Res. 1998 Apr; 33(1):29-53. PMID: 9566176; PMCID: PMC1070245.
    104. Phillips KA, Homan RK, Hiatt PH, Luft HS, Kearney TE, Heard SE, Olson KR. The costs and outcomes of restricting public access to poison control centers. Results from a natural experiment. Med Care. 1998 Mar; 36(3):271-80. PMID: 9520953.
      View in: PubMed
    105. Phillips KA, Luft HS. The policy implications of using hospital and physician volumes as "indicators" of quality of care in a changing health care environment. Int J Qual Health Care. 1997 Oct; 9(5):341-8. PMID: 9394202.
      View in: PubMed
    106. Phillips KA, Homan RK, Luft HS, Hiatt PH, Olson KR, Kearney TE, Heard SE. Willingness to pay for poison control centers. J Health Econ. 1997 Jun; 16(3):343-57. PMID: 10169305.
      View in: PubMed
    107. Phillips KA, Coates TJ, Catania JA. Predictors of follow-through on plans to be tested for HIV. Am J Prev Med. 1997 May-Jun; 13(3):193-8. PMID: 9181207.
      View in: PubMed
    108. Phillips KA, Hotlgrave DR. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention? Am J Prev Med. 1997 Jan-Feb; 13(1):18-25. PMID: 9037338.
      View in: PubMed
    109. Phillips KA, Bleecker T, Morrison KR, Sonnad SS. HIV counseling and testing of pregnant women. JAMA. 1996 Jul 24-31; 276(4):283-4. PMID: 8656538.
      View in: PubMed
    110. Stall R, Hoff C, Coates TJ, Paul J, Phillips KA, Ekstrand M, Kegeles S, Catania J, Daigle D, Diaz R. Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1; 11(2):151-60. PMID: 8556397.
      View in: PubMed
    111. Phillips KA, Bero LA. Improving the use of information in medical effectiveness research. Int J Qual Health Care. 1996 Feb; 8(1):21-30. PMID: 8680813.
      View in: PubMed
    112. Phillips KA, Catania JA. Consistency in self-reports of HIV testing: longitudinal findings from the National AIDS Behavioral Surveys. Public Health Rep. 1995 Nov-Dec; 110(6):749-53. PMID: 8570830; PMCID: PMC1381819.
    113. Phillips KA, Paul J, Kegeles S, Stall R, Hoff C, Coates TJ. Predictors of repeat HIV testing among gay and bisexual men. AIDS. 1995 Jul; 9(7):769-75. PMID: 7546423.
      View in: PubMed
    114. Phillips KA, Flatt SJ, Morrison KR, Coates TJ. Potential use of home HIV testing. N Engl J Med. 1995 May 11; 332(19):1308-10. PMID: 7708086.
      View in: PubMed
    115. Phillips KA, Coates TJ, Eversley RB, Catania JA. Who plans to be tested for HIV or would get tested if no one could find out the results? Am J Prev Med. 1995 May-Jun; 11(3):156-62. PMID: 7662394.
      View in: PubMed
    116. Phillips KA, Luft HS, Ritchie JL. The association of hospital volumes of percutaneous transluminal coronary angioplasty with adverse outcomes, length of stay, and charges in California. Med Care. 1995 May; 33(5):502-14. PMID: 7739274.
      View in: PubMed
    117. Phillips KA, Coates TJ. HIV counselling and testing: research and policy issues. AIDS Care. 1995; 7(2):115-24. PMID: 7619865.
      View in: PubMed
    118. De Zoysa I, Phillips KA, Kamenga MC, O'Reilly KR, Sweat MD, White RA, Grinstead OA, Coates TJ. Role of HIV counseling and testing in changing risk behavior in developing countries. AIDS. 1995; 9 Suppl A:S95-101. PMID: 8819575.
      View in: PubMed
    119. Lurie P, Avins AL, Phillips KA, Kahn JG, Lowe RA, Ciccarone D. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection. JAMA. 1994 Dec 21; 272(23):1832-8. PMID: 7990217.
      View in: PubMed
    120. Phillips KA. The relationship of 1988 state HIV testing policies to previous and planned voluntary use of HIV testing. J Acquir Immune Defic Syndr. 1994 Apr; 7(4):403-9. PMID: 8133450.
      View in: PubMed
    121. Phillips KA, Lowe RA, Kahn JG, Lurie P, Avins AL, Ciccarone D. The cost-effectiveness of HIV testing of physicians and dentists in the United States. JAMA. 1994 Mar 16; 271(11):851-8. PMID: 8114240.
      View in: PubMed
    122. Ritchie JL, Phillips KA, Luft HS. Coronary angioplasty. Statewide experience in California. Circulation. 1993 Dec; 88(6):2735-43. PMID: 8252686.
      View in: PubMed
    123. Phillips KA. Subjective knowledge of AIDS and use of HIV testing. Am J Public Health. 1993 Oct; 83(10):1460-2. PMID: 8214240; PMCID: PMC1694859.
    124. Phillips KA. Factors associated with voluntary HIV testing for African-Americans and Hispanics. AIDS Educ Prev. 1993; 5(2):95-103. PMID: 8323861.
      View in: PubMed
    125. Phillips KA, Rosenblatt A. Speaking in tongues: integrating economics and psychology into health and mental health services outcomes research. Med Care Rev. 1992; 49(2):191-231. PMID: 10119557.
      View in: PubMed
    126. Paringer L, Phillips KA, Hu TW. Who seeks HIV testing? The impact of risk, knowledge, and state regulatory policy on the testing decision. Inquiry. 1991; 28(3):226-35. PMID: 1833333.
      View in: PubMed
    Kathryn's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP